XML 37 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Schedule of Reconciliation of Total Consideration) (Details) (CNS Therapeutics, Inc., USD $)
In Millions, unless otherwise specified
0 Months Ended
Oct. 01, 2012
Business Acquisition [Line Items]  
Less: contingent consideration $ (6.9)
Specialty Pharmaceuticals
 
Business Acquisition [Line Items]  
Total consideration 95.0
Plus: cash assumed in the acquisition 3.6
Less: contingent consideration (6.9)
Net assets acquired $ 91.7